Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - COST OF REVENUE
Cost of Revenue EBS - Emergent BioSolutions Inc.
705 M
LAST VALUE
-3.50%
2 YEAR CAGR
16.96%
5 YEAR CAGR
27.50%
10 YEAR CAGR